• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明质酸羧甲基纤维素基生物可吸收膜(Seprafilm)减少了切口下的粘连,使非计划性再次剖腹术更安全。

Hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) reduces adhesion under the incision to make unplanned re-laparotomy safer.

机构信息

Department of Surgery, Kumamoto Regional Medical Center, 5-16-10 Honjo, Kumamoto, 860-0811, Japan.

出版信息

Surg Today. 2012 Sep;42(9):863-7. doi: 10.1007/s00595-012-0191-z. Epub 2012 May 16.

DOI:10.1007/s00595-012-0191-z
PMID:22584992
Abstract

PURPOSE

Hyaluronate carboxymethylcellulose-based bioresorbable membrane (HC membrane; Seprafilm(®)) is used to prevent postoperative adhesion. We conducted this study to assess the effectiveness of the HC membrane in reducing the severity of adhesions in patients undergoing unplanned re-laparotomy.

METHODS

Between February, 2002 and December, 2010, 123 patients underwent abdominal surgery followed by a re-laparotomy in Kumamoto Regional Medical Center. The HC membrane was placed under the first abdominal incision in 60 patients (HC membrane group), whereas it was not used in the other 63 patients (control group). We compared the medical and operative records of these two groups.

RESULTS

At the second laparotomy, adhesion under the incision was severe in many of the control group patients, but was significantly reduced in the HC membrane group. Postoperative small-bowel obstruction was significantly less frequent in the HC membrane group. According to univariate analysis of the risk factors for adhesion, prolonged operation time, blood loss, and not using an HC membrane were significantly associated with severe adhesion. Multivariate analysis revealed that only not using the HC membrane was significant.

CONCLUSION

The HC membrane effectively reduces the severity of wound adhesion, making unplanned repeated laparotomy safer.

摘要

目的

透明质酸羧甲基纤维素基生物可吸收膜(HC 膜;Seprafilm(®))用于预防术后粘连。我们进行这项研究是为了评估 HC 膜在减轻计划外再次剖腹手术患者粘连严重程度方面的有效性。

方法

2002 年 2 月至 2010 年 12 月,123 例患者在熊本地区医疗中心接受腹部手术后再次行剖腹术。60 例患者(HC 膜组)在首次腹部切口下放置 HC 膜,而另外 63 例患者(对照组)未使用 HC 膜。我们比较了这两组的医疗和手术记录。

结果

在第二次剖腹术中,对照组患者的切口下粘连严重,但在 HC 膜组中明显减轻。HC 膜组术后小肠梗阻的发生率明显较低。对粘连的危险因素进行单因素分析显示,手术时间延长、出血量和不使用 HC 膜与严重粘连显著相关。多因素分析显示,只有不使用 HC 膜是显著的。

结论

HC 膜可有效减轻伤口粘连的严重程度,使计划外重复剖腹术更安全。

相似文献

1
Hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm) reduces adhesion under the incision to make unplanned re-laparotomy safer.透明质酸羧甲基纤维素基生物可吸收膜(Seprafilm)减少了切口下的粘连,使非计划性再次剖腹术更安全。
Surg Today. 2012 Sep;42(9):863-7. doi: 10.1007/s00595-012-0191-z. Epub 2012 May 16.
2
Adhesion prevention during laparotomy: long-term follow-up of a randomized clinical trial.剖腹术中预防粘连:一项随机临床试验的长期随访。
Ann Surg. 2011 Jun;253(6):1118-21. doi: 10.1097/SLA.0b013e318217e99c.
3
Prevention of postoperative abdominal adhesions by a novel, glycerol/sodium hyaluronate/carboxymethylcellulose-based bioresorbable membrane: a prospective, randomized, evaluator-blinded multicenter study.一种新型甘油/透明质酸钠/羧甲基纤维素基生物可吸收膜预防术后腹腔粘连:一项前瞻性、随机、评估者盲法多中心研究。
Dis Colon Rectum. 2005 Jun;48(6):1130-9. doi: 10.1007/s10350-004-0954-8.
4
Comparison of the two types of bioresorbable barriers to prevent intra-abdominal adhesions in rats.两种生物可吸收屏障预防大鼠腹腔内粘连的比较。
J Gastrointest Surg. 2009 Feb;13(2):282-6. doi: 10.1007/s11605-008-0678-5. Epub 2008 Sep 7.
5
The role of Seprafilm bioresorbable membrane in adhesion prevention.Seprafilm生物可吸收膜在预防粘连中的作用。
Eur J Surg Suppl. 1997(577):49-55.
6
The use of Seprafilm in pediatric surgical patients.Seprafilm在小儿外科手术患者中的应用。
Am Surg. 2007 Aug;73(8):792-5.
7
Does sodium hyaluronate- and carboxymethylcellulose-based bioresorbable membrane (Seprafilm) decrease operative time for loop ileostomy closure?基于透明质酸钠和羧甲基纤维素的生物可吸收膜(Seprafilm)能否缩短回肠造口闭合术的手术时间?
Tech Coloproctol. 2006 Oct;10(3):187-90; discussion 190-1. doi: 10.1007/s10151-006-0278-x. Epub 2006 Sep 20.
8
Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery.Seprafilm在降低接受腹部手术的儿科手术患者再次手术风险方面的疗效。
J Pediatr Surg. 2005 Aug;40(8):1301-6. doi: 10.1016/j.jpedsurg.2005.05.015.
9
Fewer intraperitoneal adhesions with use of hyaluronic acid-carboxymethylcellulose membrane: a randomized clinical trial.使用透明质酸-羧甲基纤维素膜减少腹腔粘连:一项随机临床试验。
Ann Surg. 2002 Feb;235(2):193-9. doi: 10.1097/00000658-200202000-00006.
10
A sodium hyaluronate carboxymethylcellulose bioresorbable membrane prevents postoperative small-bowel adhesive obstruction after distal gastrectomy.透明质酸钠羧甲基纤维素生物可吸收膜预防远端胃切除术后的小肠道粘连性梗阻。
Surg Today. 2010 Mar;40(3):223-7. doi: 10.1007/s00595-008-4059-1. Epub 2010 Feb 24.

引用本文的文献

1
The Efficacy of Hyaluronic Acid in Reducing Pelvic Adhesions in Patients Undergoing Gynecologic Laparoscopic Surgery: A Meta-Analysis of Randomized Clinical Trials.透明质酸在妇科腹腔镜手术患者中减少盆腔粘连的疗效:一项随机临床试验的荟萃分析
Health Sci Rep. 2025 Jun 11;8(6):e70887. doi: 10.1002/hsr2.70887. eCollection 2025 Jun.
2
Hyaluronic acid gel application versus ovarian suspension for prevention of ovarian adhesions during laparoscopic surgery on endometrioma: a double-blind randomized clinical trial.透明质酸凝胶应用与卵巢悬吊带用于预防子宫内膜异位症腹腔镜手术中的卵巢粘连:一项双盲随机临床试验。
BMC Womens Health. 2022 Feb 11;22(1):33. doi: 10.1186/s12905-022-01607-2.
3

本文引用的文献

1
Intra-abdominal adhesions: definition, origin, significance in surgical practice, and treatment options.腹腔内粘连:定义、起源、在外科实践中的意义和治疗选择。
Dtsch Arztebl Int. 2010 Nov;107(44):769-75. doi: 10.3238/arztebl.2010.0769. Epub 2010 Nov 5.
2
A sodium hyaluronate carboxymethylcellulose bioresorbable membrane prevents postoperative small-bowel adhesive obstruction after distal gastrectomy.透明质酸钠羧甲基纤维素生物可吸收膜预防远端胃切除术后的小肠道粘连性梗阻。
Surg Today. 2010 Mar;40(3):223-7. doi: 10.1007/s00595-008-4059-1. Epub 2010 Feb 24.
3
Laparoscopic management of recurrent adhesive small-bowel obstruction: Long-term follow-up.
Feasibility of Hyaluronate Carboxymethylcellulose-Based Bioresorbable Membrane in Two-Staged Pancreatojejunostomy.
透明质酸羧甲基纤维素基生物可吸收膜在胰肠吻合术两阶段中的可行性。
World J Surg. 2020 Mar;44(3):902-909. doi: 10.1007/s00268-019-05253-y.
4
Absorptive anti-adhesion barrier for the prevention of bowel obstruction after laparoscopic colorectal cancer surgery.用于预防腹腔镜结直肠癌手术后肠梗阻的吸收性抗粘连屏障。
J Anus Rectum Colon. 2018 Mar 9;2(1):1-8. doi: 10.23922/jarc.2017-026. eCollection 2018.
5
Comparison of clinical outcomes of laparoscopic versus open surgery for recurrent hepatocellular carcinoma: a meta-analysis.腹腔镜与开腹手术治疗复发性肝细胞癌的临床结局比较:一项荟萃分析。
Surg Endosc. 2019 Nov;33(11):3550-3557. doi: 10.1007/s00464-019-06996-4. Epub 2019 Jul 24.
6
Short-term surgical outcomes of minimally invasive repeat hepatectomy for recurrent liver cancer.微创再次肝切除术治疗复发性肝癌的短期手术结果。
Surg Endosc. 2018 Jan;32(1):46-52. doi: 10.1007/s00464-017-5632-8. Epub 2017 Jun 21.
7
A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery.一项多中心、随机、对照试验,旨在评估透明质酸/羧甲基纤维素粉末粘连屏障与无屏障在结直肠腹腔镜手术中的安全性、易用性和可靠性。
Trials. 2014 Oct 27;15:413. doi: 10.1186/1745-6215-15-413.
8
Bimodal tumor-targeting from microenvironment responsive hyaluronan layer-by-layer (LbL) nanoparticles.基于微环境响应性透明质酸层层自组装纳米颗粒的双峰肿瘤靶向作用
ACS Nano. 2014 Aug 26;8(8):8374-82. doi: 10.1021/nn502861t. Epub 2014 Aug 11.
9
Antiadhesive effect and safety of sodium hyaluronate-carboxymethyl cellulose membrane in thyroid surgery.透明质酸钠-羧甲基纤维素膜在甲状腺手术中的抗粘连作用及安全性
J Korean Surg Soc. 2013 Nov;85(5):199-204. doi: 10.4174/jkss.2013.85.5.199. Epub 2013 Oct 25.
10
Comparative study for preventive effects of intra-abdominal adhesion using cyclo-oxygenase-2 enzyme (COX-2) inhibitor, low molecular weight heparin (LMWH), and synthetic barrier.环氧化酶-2(COX-2)抑制剂、低分子肝素(LMWH)和合成屏障预防腹腔粘连的效果比较研究
Yonsei Med J. 2013 Nov;54(6):1491-7. doi: 10.3349/ymj.2013.54.6.1491.
腹腔镜治疗复发性粘连性小肠梗阻:长期随访
Surg Today. 2009;39(6):493-9. doi: 10.1007/s00595-008-3906-4. Epub 2009 May 27.
4
Hyaluronic acid-carboxycellulose membrane (Seprafilm) reduces early postoperative small bowel obstruction in gastrointestinal surgery.透明质酸-羧甲基纤维素膜(Seprafilm)可降低胃肠手术术后早期小肠梗阻的发生率。
Am Surg. 2005 Oct;71(10):861-3.
5
Seprafilm does not aggravate intraperitoneal septic conditions or evoke systemic inflammatory response.施沛特不会加重腹腔内感染情况或引发全身炎症反应。
Surg Today. 2005;35(12):1054-9. doi: 10.1007/s00595-005-3085-5.
6
Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection.肠道切除术后使用Seprafilm粘连屏障减少粘连性小肠梗阻的发生
Dis Colon Rectum. 2006 Jan;49(1):1-11. doi: 10.1007/s10350-005-0268-5.
7
Bioresorbable hyaluronate-carboxymethylcellulose membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial.生物可吸收性透明质酸盐-羧甲基纤维素膜(Seprafilm)用于直肠癌手术:一项前瞻性随机临床试验。
Surg Today. 2005;35(11):940-5. doi: 10.1007/s00595-005-3061-0.
8
Efficacy of Seprafilm for reducing reoperative risk in pediatric surgical patients undergoing abdominal surgery.Seprafilm在降低接受腹部手术的儿科手术患者再次手术风险方面的疗效。
J Pediatr Surg. 2005 Aug;40(8):1301-6. doi: 10.1016/j.jpedsurg.2005.05.015.
9
A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine.一项关于Seprafilm粘连屏障在肠道腹盆腔手术中安全性的前瞻性、随机、多中心对照研究。
Dis Colon Rectum. 2003 Oct;46(10):1310-9. doi: 10.1007/s10350-004-6739-2.
10
Seprafilm: a retrospective preliminary evaluation of the impact on short-term oncologic outcome in colorectal cancer.Seprafilm:对结直肠癌短期肿瘤学结局影响的回顾性初步评估
Dis Colon Rectum. 2002 Oct;45(10):1376-80. doi: 10.1007/s10350-004-6428-1.